Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
Alexander J Thompson, Andrew J Muir, Mark S Sulkowski, Dongliang Ge, Jacques Fellay, Kevin V Shianna, Thomas Urban, Nezam H Afdhal, Ira M Jacobson, Rafael Esteban, Fred Poordad, Eric J Lawitz, Jonathan McCone, Mitchell L Shiffman, Greg W Galler, William M Lee, Robert Reindollar, John W King, Paul Y Kwo, Reem H Ghalib Show all
Gastroenterology | W B SAUNDERS CO-ELSEVIER INC | Published : 2010
This study was funded by Schering-Plough Research Institute, Kenilworth, NJ; Alexander Thompson received funding support from the Duke Clinical Research Institute, the Richard B. Boebel Family Fund, the National Health and Medical Research Council of Australia, and the Gastroenterology Society of Australia and the Royal Australasian College of Physicians.r Jennifer King, PhD, provided editorial assistance in preparing the manuscript; she was funded by the Duke Clinical Research Institute, Duke University. The sponsor did not provide any funding for Dr King or have any contact with her.